Anti-glycan antibodies as biomarkers for diagnosis and prognosis

Lupus

Volumn 15, Issue 7, 2006, Pages 442-450

  Dotan, Nir ^a   Altstock, R T ^a   Schwarz, M ^a   Dukler, A ^a  

^a Glycominds Ltd   (Israel)

Author keywords

Antibodies; Crohn's disease, diagnosis; Glycan array; Multiple sclerosis; Prognosis

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; CHITOBIOSIDE ANTIBODY; GLYCAN; GLYCAN ANTIBODY; GLYCAN(ALPHA1,4)GLYCAN(ALPHA) IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN G; LAMINARIBIOSIDE ANTIBODY; MANNOBIOSIDE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CROHN DISEASE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENTERITIS; GASTROINTESTINAL DISEASE; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SURGICAL RISK; ULCERATIVE COLITIS;

ANTIBODIES; BIOLOGICAL MARKERS; CROHN DISEASE; HUMANS; MULTIPLE SCLEROSIS; POLYSACCHARIDES; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 33746612051     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2331oa     Document Type: Article

References (53)

1. Templin MF, Stoll D, Schrenk M, Traub PC, Vohringer CF, Joos TO. Protein microarray technology. Trends Biotechnol 2002; 20: 160-166.
2. Lal SP, Christopherson RI, dos Remedies CG. Antibody arrays: an embryonic but rapidly growing technology. Drug Discov Today 2002; 7: S143-S149.
3. Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer 2003; 3: 267-275.
4. Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572-577.
5. Feizi T, Chai W. Oligosaccharide microarrays to decipher the glyco code. Nat Rev Mol Cell Biol 2004; 5: 582-588.
6. Smolka M, Zhou H, Aebersold R. Quantitative protein profiling using two-dimensional gel electrophoresis, isotope-coded affinity tag labeling, and mass spectrometry. Mol Cell Proteomics 2002; 1: 19-29.
7. MacCoss MJ, McDonald WH, Saraf A et al. Shotgun identification of protein modifications from protein complexes and lens tissue. PNAS 2002; 99: 7900-7905.
8. Mann M, Ong SE, Gronborg M, Steen H, Jensen ON, Pandey A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol 2002; 20: 261-268.
9. Kaji H, Saito H, Yamauchi Y et al. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat Biotechnol 2003; 21: 667-072.
10. Zhang H, Li XJ, Martin DB, Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol 2003; 21: 660-666.
11. Nimrichter L, Gargir A, Gortler M et al. Intact cell adhesion to glycan microarrays. Glycobiology 2004; 14: 197-203.
12. Sharon N. Complex carbohydrates - their chemistry, biosynthesis, and functions, 2nd edition, Addison-Wesley Publishing Company, 1975.
13. Laine RA. A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 × 10(12) structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems. Glycobiology 1994; 4: 759-767.
14. Feizi T. Progress in deciphering the information content of the 'glycome'-a crescendo in the closing years of the millennium. Glycoconj J 2000; 17: 553-565.
15. Feizi T. Carbohydrate-mediated recognition systems in innate immunity. Immunol Rev 2000; 173: 79-88.
16. Crocker PR, Feizi T. Carbohydrate recognition systems: functional triads in cell-cell interactions. Curr Opin Struct Biol 1996; 6: 679-691.
17. Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science 2001; 291: 2364-2369.
18. Karlsson KA. Meaning and therapeutic potential of microbial recognition of host glycoconjugates. Mol Microbiol 1998; 29: 1-11.
19. McEver RP. Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J 1997; 14: 585-591.
20. McMorrow IM, Comrack CA, Sachs DH, DerSimonian H. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope. Transplantation 1997; 64: 501-510.
21. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002; 125: 2591-2625.
22. Schwarz M, Spector L, Gargir A et al. A new kind of carbohydrate array, its use for profiling anti-glycan antibodies, and the discovery of a novel human cellulose-binding antibody. Glycobiology 2003; 13: 749-754.
23. Ratner DM, Adams EW, Su J, O'Keefe BR, Mrksich M, Seeberger PH. Probing protein-carbohydrate interactions with microarrays of synthetic oligosaccharides. Chem Biol 2004; 11: 739-740.
24. Feizi T, Fazio F, Chai W, Wong CH. Carbohydrate microarrays - a new set of technologies at the frontiers of glycomics. Curr Opin Struct Biol 2003; 13: 637-645.
25. Drickamer K, Taylor ME. Glycan arrays for functional glycomics. Genome Biol 2002; 3: 1034.1-1034.4.
26. Love KR, Seeberger PH. Carbohydrate arrays as tools for glycomics. Angew Chem Int Ed Engl 2002; 41: 3583-3586.
27. Galanina OE, Mecklenburg M, Nifantiev NE, Pazynina GV, Bovin NV. GlycoChip: multiarray for the study of carbohydrate-binding proteins. Lab Chip 2003; 3: 260-265.
28. Guo Y, Feinberg H, Conroy E et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 2004; 11: 591-598.
29. Wang D, Liu S, Trummer BJ, Deng C, Wang A. Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells. Nat Biotechnol 2002; 20: 275-281.
30. Fukui S, Feizi T, Galustian C, Lawson AM, Chai W. Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nat Biotechnol 2002; 20: 1011-1017.
31. Willats WG, Rasmussen SE, Kristensen T, Mikkelsen JD, Knox JP. Sugar-coated microarrays: a novel slide surface for the high-throughput analysis of glycans. Proteomics 2002; 2: 1666-1671.
32. Fazio F, Bryan MC, Blixt O, Paulson JC, Wong CH. Synthesis of sugar arrays in microtiter plate. J Am Chem Soc 2002; 124: 14397-14402.
33. Bryan MC, Fazio F, Lee HK et al. Covalent display of oligosaccharide arrays in microtiter plates. J Am Chem Soc 2004; 126: 8640-8641.
34. Park S, Lee MR, Pyo SJ, Shin I. Carbohydrate chips for studying high-throughput carbohydrate-protein interactions. J Am Chem Soc 2004; 126: 4812-4819.
35. Houseman BT, Mrksich M. Carbohydrate arrays for the evaluation of protein binding and enzymatic modification. Chem Biol 2002; 9: 443-454.
36. Park S, Shin I. Fabrication of carbohydrate chips for studying protein-carbohydrate interactions. Angew Chem Int Ed 2002; 41: 3180-3182.
37. Schwarz M, Spector L, Gortler M et at. Serum anti-Glc(α1,4) Glc(α) antibodies as a biomarker for relapsing remitting multiple sclerosis. J Neural Sci 2006; 244: 59-68.
38. Freedman MS, Laks J, Dotan N et al. Anti-Glc(alpha 1,4)Glc(alpha) IgM antibodies for predict the development of relapsing-remitting multiple sclerosis after the first neurological event. Mult Scler 2005; 11: S180 (abstract).
39. Dotan I, Fishman S, Kariv R et al. Anti-laminaribioside carbohydrate antibodies (ALCA) and anti-chitobioside carbohydrate antibodies (ACCA) are novel serological markers specific for Crohn's disease. Gastroentrology 2004; 125: A203 (abstract).
40. Altstock RT, Shtevi A, Karban A et al. Improved IBD diagnosis via ELISA detecting novel antibodies: anti-chitobioside carbohydrate antibodies (ACCA), anti-laminaribioside carbohydrate antibodies (ALCA), and anti-mannobioside carbohydrate antibodies (AMCA). Gastroentrology 2005; 128: A-303 (abstract).
41. Dotan I, Fishman S, Dgani Y et al. Antibodies against laminaribioside and chitobioside are novel serological markers in Crohn's disease. Gastroentrology 2006 (in press).
42. Watkins WM. Blood group substances. Science 1966; 152: 172-181.
43. Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 2005; 83: 674-686.
44. Menge T, Lalive PH, von Budingen HC, Cree B, Hauser SL, Genain CP. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis. J Allergy Clin Immunol 2005; 116: 453-459.
45. Lolli F, Mulinacci B, Carotenuto A et al. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. Proc Natl Acad Sci USA 2005; 102: 10273-10278.
46. Lolli F, Mazzanti B, Pazzagli M et al. The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis. J Neuroimmunol 2005; 167: 131-137.
47. Sendid B, Colombel JF, Jacquinot PM et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996; 3: 219-226.
48. Israeli E, Grotto I, Gilburd B et al. Anti-saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005; 54: 1232-1236.
49. Mow WS, Vasiliauskas EA, Lin YC et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004; 126: 414-424.
50. Ferrante M, Pierik M, Henckaerts L et al. A panel of serological antibodies (gASCA, Omp + , ACCA, ALCA and AMCA) predicts complicated disease course and surgery in Crohn's disease. Gastroentrology 2006 (abstract in press).
51. Henckaerts L, Pierik M, Claes K et al. Mutations in innate immune receptors modulate the serologic response to microbial antigens in patients with inflammatory bowel disease. Gastroentrology 2006 (abstract in press).
52. Cristofanilli M. Circulating tumor cells and novel biomarkers for prognostics and biological of breast cancer. Breast Cancer Research 2005; 7(Suppl 1): S9 (abstract).
53. Wang D, Lu J. Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV. Physiol Genomics 2004; 18: 245-248.